
How 2023 Can Impact Your Biotech/Pharma Manufacturing Plan
As the JPM meeting of 2023 closes, what can we learn from the last year and project into 2023 for biotech/pharma contract manufacturing? Responding to
As the JPM meeting of 2023 closes, what can we learn from the last year and project into 2023 for biotech/pharma contract manufacturing? Responding to
Updated October 16, 2022 In 2008-2010, the economic downturn in biotech wreaked havoc on the unprepared industry. Fast forward to late 2022, and the economic
Opinion: Wayne Woodard, CEO Argonaut Manufacturing Services In early September 2020, I wrote an opinion piece titled “Bring Manufacturing Back to the USA” that generated
Getting Back to Normal Operations The FDA recently recommended that “manufacturers of devices authorized under EUA’s (to) plan now, while the pandemic is ongoing, their
We made it happen. We brought back our Oktoberfest Annual Open House and a grand time was had. It felt incredible to meet with our
As the Fourth of July approaches and we celebrate Independence Day, there is a renewed optimism in the air that the worst of the pandemic
As an assay developer, you understand the importance of having quality controls and standards for your assay, but what does it really take to manufacture
In 2016, Argonaut opened its doors as a true “greenfield startup.” No customers, no assets. Just a good idea and a few hardworking individuals driven to
(Carlsbad, CA) May 12, 2021 – Argonaut Manufacturing Services, a contract manufacturing organization (CMO) serving the life sciences, molecular diagnostics, and biopharma industries, announced today
Argonaut Manufacturing Services (‘Argonaut’), a leading contract manufacturing organization for Life Science, Diagnostic, and BioPharma markets today announced the launch of a new service offering